Sangamo Therapeutics
SGMO
SGMO
124 hedge funds and large institutions have $196M invested in Sangamo Therapeutics in 2016 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 44 increasing their positions, 30 reducing their positions, and 25 closing their positions.
Holders
124
Holders Change
-12
Holders Change %
-8.82%
% of All Funds
3.31%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
13
Increased
44
Reduced
30
Closed
25
Calls
$5.37M
Puts
$1.49M
Net Calls
+$3.88M
Net Calls Change
-$564K
Top Buyers
| 1 |
O
1
OrbiMed
New York
|
$3.85M |
| 2 |
NI
2
Numeric Investors
Boston,
Massachusetts
|
$4.65M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$11.2M |
| 4 |
4
Renaissance Technologies
New York
|
$2.75M |
| 5 |
5
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$3.69M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
151
Parallax Volatility Advisers
San Francisco,
California
| – | – | – | – |
|
|
HT
152
HAP Trading
New York
| – | – | – | – |
|